Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Modified-Release Drug Delivery Systems: Stimuli-Activated01:30

Modified-Release Drug Delivery Systems: Stimuli-Activated

153
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
153
Modified-Release Drug Delivery Systems: Rate-Programmed II01:19

Modified-Release Drug Delivery Systems: Rate-Programmed II

109
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
109
Oral Drug Delivery Systems: Continuous-Release Systems01:26

Oral Drug Delivery Systems: Continuous-Release Systems

273
Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...
273

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cellulose-Based Nanofibers in Wound Dressing.

Biomimetics (Basel, Switzerland)·2025
Same author

Fabrication and Characterization of a Stretchable Sodium Alginate Hydrogel Patch Combined with Silicon Nitride and Metalized Halloysite Nanotubes to Develop a Chronic Wound Healing Treatment.

International journal of molecular sciences·2025
Same author

Mechanical Wear of Degraded Articular Cartilage.

Annals of biomedical engineering·2025
Same author

Herbal Therapies for Cancer Treatment: A Review of Phytotherapeutic Efficacy.

Biologics : targets & therapy·2024
Same author

Osteomacs promote maintenance of murine hematopoiesis through megakaryocyte-induced upregulation of Embigin and CD166.

Stem cell reports·2024
Same author

Repeated mild traumatic brain injury in mice elicits long term innate immune cell alterations in blood, spleen, and brain.

Journal of neuroimmunology·2023

Related Experiment Video

Updated: Apr 20, 2026

Injectable Supramolecular Polymer-Nanoparticle Hydrogels for Cell and Drug Delivery Applications
09:39

Injectable Supramolecular Polymer-Nanoparticle Hydrogels for Cell and Drug Delivery Applications

Published on: February 7, 2021

9.3K

Nanoenhanced hydrogel system with sustained release capabilities.

Sonali Karnik1, Kanesha Hines1, David K Mills1,2

  • 1Center for Biomedical Engineering and Rehabilitation Science, Louisiana Tech University, Ruston, Louisiana, 71272.

Journal of Biomedical Materials Research. Part A
|November 27, 2014
PubMed
Summary
This summary is machine-generated.

New alginate/halloysite nanotube nanocomposites enable sustained, low-level release of bone morphogenetic proteins (BMPs). These materials significantly enhance osteoblast behavior, promoting tissue repair and regeneration.

Keywords:
growth factorshalloysite nanotubesosteoblastssustained releasetissue repair

More Related Videos

Alternating Magnetic Field-Responsive Hybrid Gelatin Microgels for Controlled Drug Release
09:11

Alternating Magnetic Field-Responsive Hybrid Gelatin Microgels for Controlled Drug Release

Published on: February 13, 2016

10.5K
Microwave-assisted Functionalization of Polyethylene glycol and On-resin Peptides for Use in Chain Polymerizations and Hydrogel Formation
15:33

Microwave-assisted Functionalization of Polyethylene glycol and On-resin Peptides for Use in Chain Polymerizations and Hydrogel Formation

Published on: October 29, 2013

30.0K

Related Experiment Videos

Last Updated: Apr 20, 2026

Injectable Supramolecular Polymer-Nanoparticle Hydrogels for Cell and Drug Delivery Applications
09:39

Injectable Supramolecular Polymer-Nanoparticle Hydrogels for Cell and Drug Delivery Applications

Published on: February 7, 2021

9.3K
Alternating Magnetic Field-Responsive Hybrid Gelatin Microgels for Controlled Drug Release
09:11

Alternating Magnetic Field-Responsive Hybrid Gelatin Microgels for Controlled Drug Release

Published on: February 13, 2016

10.5K
Microwave-assisted Functionalization of Polyethylene glycol and On-resin Peptides for Use in Chain Polymerizations and Hydrogel Formation
15:33

Microwave-assisted Functionalization of Polyethylene glycol and On-resin Peptides for Use in Chain Polymerizations and Hydrogel Formation

Published on: October 29, 2013

30.0K

Area of Science:

  • Biomaterials Science
  • Tissue Engineering
  • Nanotechnology

Background:

  • Alginate hydrogels are widely used for tissue engineering scaffolds.
  • Halloysite nanotubes (HNTs) can be incorporated to modify hydrogel properties.
  • Bone morphogenetic proteins (BMPs) are crucial for bone formation and regeneration.

Purpose of the Study:

  • To develop and characterize alginate/HNT nanocomposites for sustained BMP release.
  • To investigate the effect of BMP-doped nanocomposites on osteoblast behavior.
  • To evaluate the potential of these materials for enhancing tissue repair.

Main Methods:

  • Fabrication of alginate/HNT nanocomposites doped with BMP-2, BMP-4, or BMP-6.
  • Seeding of osteoblasts within the hydrogel nanocomposites.
  • Assessment of cell proliferation, phenotypic expression, and mineralization over 28 days.
  • Analysis of BMP release profiles.

Main Results:

  • BMP-doped alginate/HNT nanocomposites enhanced osteoblast proliferation, differentiation, and mineralization compared to controls.
  • Sustained release of BMP-2 at picogram levels over 7 days was observed.
  • BMP-4 and BMP-6 demonstrated significant osteogenic effects, with combined BMP-4 and BMP-6 showing enhanced differentiation.
  • Increased HNT content improved hydrogel structural integrity and surface topography.

Conclusions:

  • Alginate/HNT nanocomposites provide a promising platform for sustained delivery of BMPs.
  • These materials effectively promote osteoblast activity, indicating potential for bone tissue regeneration.
  • The enhanced structural properties and controlled growth factor release suggest reduced need for invasive treatments.